Biomarker Testing in Non-Small Cell Lung Cancer A Clinician's Perspective

被引：5
|
作者：
Bernicker, Eric [1 ]
机构：
[1] Houston Methodist Hosp, Thorac Med Oncol, Houston, TX 77030 USA
来源：
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE | 2015年 / 139卷 / 04期
关键词：
PHASE-II TRIAL; 1ST-LINE TREATMENT; OPEN-LABEL; EGFR; CHEMOTHERAPY; MUTATIONS; ERLOTINIB; CARBOPLATIN; COMBINATION; PACLITAXEL;
D O I：
10.5858/arpa.2014-0085-ED
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
[No abstract available]
引用
收藏
页码：448 / 450
页数：3
相关论文
共 50 条
  • [21] Osteopontin is a prognostic biomarker in non-small cell lung cancer
    Rud, Ane Kongsgaard
    Boye, Kjetil
    Oijordsbakken, Miriam
    Lund-Iversen, Marius
    Halvorsen, Ann Rita
    Solberg, Steinar K.
    Berge, Gisle
    Helland, Aslaug
    Brustugun, Odd Terje
    Maelandsmo, Gunhild M.
    BMC CANCER, 2013, 13
  • [22] Predictive Biomarker Testing for Programmed Cell Death 1 Inhibition in Non-Small Cell Lung Cancer
    Sheffield, Brandon S.
    Geller, Georgia
    Pleasance, Erin
    Zachara-Szczakowski, Susanna
    Milne, Katy
    Kalloger, Steve E.
    Zhao, Eric
    Bidnur, Samir
    Jones, Martin
    Nelson, Brad H.
    Yip, Stephen
    Marra, Marco A.
    Laskin, Janessa
    Ho, Cheryl
    Ionescu, Diana
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S199 - S199
  • [23] Clinical Impact of Rapid Biomarker Testing in Non-Small Cell Lung Cancer in a Community Setting
    Matthews, Priscilla
    Beharry, Andrea
    Nematollahi, Massey
    Bendzsak, Anna
    Irshad, Kashif
    Cheema, Parneet
    Sheffield, Brandon
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1802 - 1802
  • [24] Using Nurse Navigators to Improve Timeliness of Biomarker Testing for Non-Small Cell Lung Cancer
    Bostelman, Chelsea
    Elpers, Shannon
    Williams, Pamela
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2024, 28 (06) : 589 - 592
  • [25] Current and future trends in non-small cell lung cancer biomarker testing: The American experience
    VanderLaan, Paul A.
    Roy-Chowdhuri, Sinchita
    CANCER CYTOPATHOLOGY, 2020, 128 (09) : 629 - 636
  • [26] PULMONOLOGISTS' ATTITUDES AND ROLE IN PRECISION MEDICINE BIOMARKER TESTING FOR NON-SMALL CELL LUNG CANCER
    Fox, Adam
    Rudzinski, Mark
    Nietert, Paul
    Silvestri, Gerard A.
    CHEST, 2023, 164 (04) : 6503A - 6504A
  • [27] Pulmonologists' Attitudes and Role in Precision Medicine Biomarker Testing for Non-Small Cell Lung Cancer
    Fox, Adam H.
    Rudzinski, Mark A.
    Nietert, Paul J.
    Silvestri, Gerard A.
    CHEST, 2024, 166 (05) : 1229 - 1238
  • [28] Time-to-treatment for metastatic non-small cell lung cancer in the era of biomarker testing
    Akanbi, Maxwell Oluwole
    Kenmoe, Jerry
    Adekolujo, Samuel O.
    Saleem, Muhammad
    Koduru, Ujwala
    Hrinczenko, Borys
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [29] Biomarker Testing Practices for Non-small Cell Lung Cancer: A Survey of Veterans Affairs Facilities
    Vlachos, E. M.
    Dellitalia, J.
    Rubinstein, I.
    Maurice, N. M.
    Flores, N.
    Tanner, N. T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [30] Clinical Impact of Rapid Biomarker Testing in Non-Small Cell Lung Cancer in a Community Setting
    Matthews, Priscilla
    Beharry, Andrea
    Nematollahi, Massey
    Bendzsak, Anna
    Irshad, Kashif
    Cheema, Parneet
    Sheffield, Brandon
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1802 - 1802
12345